Order Article Reprints

Abo M, Shigematsu T, Hara H, Matsuda Y, Nimura A, Yamashita Y, Takahashi K. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase. Toxins. 2020; 12(2):127. https://doi.org/10.3390/toxins12020127

Abo, Masahiro, Takashi Shigematsu, Hiroyoshi Hara, Yasuko Matsuda, Akinori Nimura, Yoshiyuki Yamashita, and Kaoru Takahashi. 2020. "Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase" Toxins 12, no. 2: 127. https://doi.org/10.3390/toxins12020127

Abo, M., Shigematsu, T., Hara, H., Matsuda, Y., Nimura, A., Yamashita, Y., & Takahashi, K. (2020). Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase. Toxins, 12(2), 127. https://doi.org/10.3390/toxins12020127